Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: FWIW...response from IR says that TPL dispute has not delayed USPTO decisions.
Dear Mr. Xxxxxxx:
The dispute with TPL has not delayed the reexamination of PTSC patents with the U.S. Patent and Trademark Office.

Investor Relations
Patriot Scientific Corporation

GLTAL
Share
New Message
Please login to post a reply